Horizon Pharma

- NASDAQ:HZNP
Last Updated 2024-03-26
  • Horizon Therapeutics is focused on the development of prescription drugs for mild to moderate pain relief and arthritis.
  • Locations

    • Northbrook IL
  • Total Funding (USD)

    150.0 million
  • Industries

    Cyber Security
  • Security

    Type: ORD
    CUSIP: 00BQPVQZ6
    ISIN: IE00BQPVQZ61
Filter date
All
Bookmark Created by Last updated
Test Long URL sangwon.seo.old 2019-09-24
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.